0001213900-14-000008.txt : 20140102 0001213900-14-000008.hdr.sgml : 20140101 20140102115736 ACCESSION NUMBER: 0001213900-14-000008 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140102 DATE AS OF CHANGE: 20140102 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Lion Biotechnologies, Inc. CENTRAL INDEX KEY: 0001425205 STANDARD INDUSTRIAL CLASSIFICATION: ARRANGEMENT OF TRANSPORTATION OF FREIGHT & CARGO [4731] IRS NUMBER: 753254381 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-85384 FILM NUMBER: 14500717 BUSINESS ADDRESS: STREET 1: 21900 BURBANK BLVD. STREET 2: THIRD FLOOR CITY: WOODLAND HILLS STATE: CA ZIP: 91367 BUSINESS PHONE: 818-992-3126 MAIL ADDRESS: STREET 1: 21900 BURBANK BLVD. STREET 2: THIRD FLOOR CITY: WOODLAND HILLS STATE: CA ZIP: 91367 FORMER COMPANY: FORMER CONFORMED NAME: Genesis Biopharma, Inc DATE OF NAME CHANGE: 20100319 FORMER COMPANY: FORMER CONFORMED NAME: FREIGHT MANAGEMENT CORP DATE OF NAME CHANGE: 20080128 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ALPHA CAPITAL ANSTALT CENTRAL INDEX KEY: 0001140358 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: PRADAFAUT 7 STREET 2: FURSTENTUMS 1490 CITY: VADUZ LIECHTENSTEIN STATE: C4 ZIP: 99999 BUSINESS PHONE: 0114232376363 MAIL ADDRESS: STREET 1: PRADAFAUT 7 STREET 2: FURSTENTUMS 1490 CITY: VADUZ LIECHTENSTEIN STATE: C4 ZIP: 99999 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA CAPITAL AKTIENGESELLSCHAFT DATE OF NAME CHANGE: 20010510 SC 13G 1 sc13g0114alpha_lionbio.htm SCHEDULE 13G sc13g0114alpha_lionbio.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. __)

LION BIOTECHNOLOGIES, INC. 
(Name of Issuer)
 
COMMON STOCK
(Title of Class of Securities)
 
37182R102
(CUSIP Number)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed: x  Rule 13d-1(c)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
(Continued on following page(s)
 
Page 1 of 4 Pages
 
 
 
 

CUSIP No. 37182R102
  
13G
  
Page 2 of 4 Pages

1.   NAMES OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

            Alpha Capital Anstalt

2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
                                                                 (a)   o
                                                                 (b)   o

3.   SEC USE ONLY

 
4.   CITIZENSHIP OR PLACE OF ORGANIZATION

Liechtenstein
 
5.   SOLE VOTING POWER, NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON – 1,400,000 Common Stock

 
6.   SHARED VOTING POWER - None

 
7.   SOLE DISPOSITIVE POWER – 1,400,000 shares of Common Stock

 
8.   SHARED DISPOSITIVE POWER – None

 
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -

1,400,000 shares of Common Stock
 
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                                         o
 
 
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

7.197%
 
12. TYPE OF REPORTING PERSON
 
CO
 
 
 
 

CUSIP No. 37182R102
  
13G
  
Page 3 of 4 Pages

ITEM 1 (a) NAME OF ISSUER: Lion Biotechnologies Inc.

ITEM 1 (b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

             10960 Wilshire Blvd., Suite 1050, Los Angeles, CA

ITEM 2 (a) NAME OF PERSON FILING: Alpha Capital Anstalt

ITEM 2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

Pradafant 7, Furstentums 9490, Vaduz, Liechtenstein

ITEM 2 (c) CITIZENSHIP: Liechtenstein

ITEM 2 (d) TITLE OF CLASS OF SECURITIES: Common Stock

ITEM 2 (e) CUSIP NUMBER: 37182R102

ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B):  Not applicable

ITEM 4 OWNERSHIP

         (a) AMOUNT BENEFICIALLY OWNED: 1,400,000 Shares of Common Stock

         (b) PERCENT OF CLASS: 7.197%

         (c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:

              (i)   SOLE POWER TO VOTE OR DIRECT THE VOTE

1,400,000 Shares

              (ii)  SHARED POWER TO VOTE OR DIRECT THE VOTE

0 Shares

              (iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

1,400,000 Shares

              (iv) SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

0 Shares

 
 
 

CUSIP No. 37182R102
  
13G
  
Page 4 of 4 Pages

ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

Not applicable

ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

Not applicable

ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

Not applicable

ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP

Not applicable

ITEM 9 NOTICE OF DISSOLUTION OF GROUP

Not applicable
 
SIGNATURE

         After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 
January 2, 2014
 
(Date)
   
 
/s/ Konrad Ackerman
 
(Signature)
   
 
Konrad Ackerman, Director
 
(Name/Title)